Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors

被引：0

作者：

Maurizio Lucchesi

Milena Guidi

Carla Fonte

Silvia Farina

Patrizio Fiorini

Claudio Favre

Maurizio de Martino

Iacopo Sardi

机构：

[1] Meyer Children’s University Hospital,Neuro

[2] Meyer Children’s University Hospital,Oncology Unit, Department of Pediatric Oncology

[3] University of Florence,Neonatal Intensive Care Unit, Department of Pediatrics

来源：

Cancer Chemotherapy and Pharmacology | 2016年 / 77卷

关键词：

High-dose methotrexate; Pediatric brain tumors; Early infants; Chemotherapy toxicities; Pharmacokinetics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：857 / 864

页数：7

共 50 条

[31] Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high-dose methotrexate based on individual pharmacokinetics: A retrospective study
Nagamine, Ayumu
Araki, Takuya
Yashima, Hideaki
Kamimura, Akane
Shiraishi, Takumi
Yanagawa, Takashi
Obayashi, Kyoko
Yamamoto, Koujirou
ONCOLOGY LETTERS, 2023, 25 (02)
[32] HIGH-DOSE METHOTREXATE COMBINED WITH 8 IN 1 IN THE TREATMENT OF CLASS-III/IV BRAIN-TUMORS IN CHILDREN
SCHWABE, D
GUSSETIS, E
JACOBI, G
GEREIN, V
KORNHUBER, B
KLINISCHE PADIATRIE, 1992, 204 (02): : 72 - 77
[33] Feasibility of tandem high-dose chemotherapy and autologous peripheral blood stem cell rescue in infants with brain tumors
Marques, Juliana
Sasaki, Marcia
Gouveia, Roseane
Ginani, Valeria
Seber, Adriana
BONE MARROW TRANSPLANTATION, 2018, 53 : 852 - 852
[34] NEUROBLASTOMA IN INFANTS AGED LESS-THAN 6 MONTHS - IS MORE AGGRESSIVE TREATMENT NECESSARY - A REPORT FROM THE PEDIATRIC ONCOLOGY STUDY-GROUP OF THE KYUSHU AREA
SUITA, S
ZAIZEN, Y
SERA, Y
TAKAMATSU, H
MIZOTE, H
OGAMI, H
KUROSAKI, N
UEDA, K
TASAKA, H
MIYAZAKI, S
KAWAKAMI, K
TSUNEYOSHI, M
YANO, H
AKIYAMA, H
IKEDA, K
JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (05) : 715 - 721
[35] THE UPPER LIMIT OF THE METHOTREXATE (MTX) CSF LEVELS ACHIEVABLE IN CHILDREN WITH BRAIN TUMORS TREATED WITH HIGH DOSE INTRAVENOUS MTX
Cohen, Ian
Toledano, Helen
Ash, Shifra
Goshen, Yaacov
Cohen, Eytan
Yaniv, Isaac
PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 728 - 728
[36] PERI-TRANSPLANT RADIATION THERAPY FOR YOUNG CHILDREN TREATED WITH HIGH-DOSE CHEMOTHERAPY FOR PRIMARY BRAIN TUMORS
Milgrom, Sarah
Koo, Jane
Foreman, Nicholas
Liu, Arthur
Campbell, Kristen
Dorris, Kathleen
Green, Adam
Dahl, Nathan
Donson, Andrew
Vibhakar, Rajeev
Mulcahy-Levy, Jean
NEURO-ONCOLOGY, 2022, 24 : 177 - 177
[37] The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group
Ryan J. Beechinor
Patrick A. Thompson
Michael F. Hwang
Ryan C. Vargo
Lisa R. Bomgaars
Jacqueline G. Gerhart
ZoAnn E. Dreyer
Daniel Gonzalez
Clinical Pharmacokinetics, 2019, 58 : 899 - 910
[38] The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group
Beechinor, Ryan J.
Thompson, Patrick A.
Hwang, Michael F.
Vargo, Ryan C.
Bomgaars, Lisa R.
Gerhart, Jacqueline G.
Dreyer, ZoAnn E.
Gonzalez, Daniel
CLINICAL PHARMACOKINETICS, 2019, 58 (07) : 899 - 910
[39] Are High-Dose Perioperative Steroids Necessary in Patients Undergoing Colorectal Surgery Treated with Steroid Therapy Within the Past 12 Months?
Zaghiyan, Karen
Melmed, Gil
Murrell, Zuri
Fleshner, Phillip
AMERICAN SURGEON, 2011, 77 (10) : 1295 - 1299
[40] Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age
Cirillo, Iolanda
Vaccaro, Nicole
Castaneda-Ruiz, Bibiana
Redman, Rebecca
Cossey, Veerle
Bradley, John S.
Allegaert, Karel
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4742 - 4749

← 1 2 3 4 5 →